Becton, Dickinson and Company (BD): FDA 510(k) Clearances, Shared Predicate Lineage, and Recall History (1976 to 2026)

Consolidated U.S. FDA 510(k) premarket clearance cohort in Microbiology (primary filing hub: NJ) reconciled with CDRH and openFDA historical recall notices from 1976 to 2026.

Review 2,013 FDA 510(k) clearances, 308 recalled K-numbers, and 1,632 cumulative 1976 to 2026 CDRH recall notices for Becton, Dickinson and Company (BD) on Predicate Ledger.

Reconciled U.S. FDA 510(k) and Recall Summary for Becton, Dickinson and Company (BD)
Regulatory MetricVerified Value
Entity ClassificationConsolidated MedTech Parent (61 FDA applicant names)
Clinical Advisory SpecialtyMicrobiology (Panel MI)
Cleared FDA 510(k) Submissions (1976 to 2026)2,013 clearances (103 California, 5.1%)
Cleared 510(k)s Linked to a Recall Notice308 K-numbers (15.30% of cleared cohort)
Cumulative Historical Recall Notices (1976 to 2026)1,632 notices (90 Class I, 1,507 Class II, 35 Class III)
Currently Open vs Historical Recall StatusCumulative 1976 to 2026 FDA archive total (1,632 notices); verify live open vs terminated status per notice in dossier
Implantable and Life-Sustaining Clearances258 implantable (12.8%) and 90 life-sustaining
Median FDA 510(k) Review Duration67 days (90th percentile: 234 days)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Becton, Dickinson and Company (BD) across sibling Meru public-data platforms.

Cumulative recall counts span 1976 to 2026 across U.S. FDA CDRH and openFDA public archives and combine closed historical notices with any currently open field actions. Browse all device cohorts, 20 clinical specialties, Shared 510(k) Predicate Lineage Stage, or reconciliation methodology.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.